Search

Management of DMO and PDR in 2019

An evidence-based approach to the management of diabetic macular oedema (DMO) and proliferative diabetic retinopathy (PDR) in 2019 was outlined by Sobha Sivaprasad, UK, in presentations during the Diabetic Retina scientific session September 6 2019, at the 19th European Society...

COVID-19 and Charles Bonnet Syndrome

As COVID-19 rips through the country, it is – of course – imperative that we stay at home to try and prevent the virus spreading through the whole community. We are all aware of the need to take special care...

Use of a smartphone repair microscope for microsurgical suturing simulation

Suturing ocular tissues under microscopic guidance is a skill that has declined in frequency, with the majority of cataract operations being sutureless. With the recent COVID-19 outbreak, training opportunities in theatre have declined further, given elective surgery cancellations. Subsequently, trainees...

In conversation with Prof Carrie MacEwen, Chair of The Way Forward and President, The Royal College of Ophthalmologists

Prof Carrie MacEwen. Scope for optimising capacity within the Hospital Eye Service (HES)? The demand for ophthalmic care continues to grow with no increase in capacity. In order to be able to continue to deliver adequate care ophthalmologists have devised...

Thyroid eye disease

Thyroid eye disease (TED) is an autoimmune condition with a spectrum of signs and symptoms, usually associated with Graves’ hyperthyroidism. The diagnosis is based on history and physical examination but there are further investigations that can aid diagnosis if unclear....

The lived experience of benign essential blepharospasm

Benign essential blepharospasm (BEB) is a rare neurological condition which causes involuntary sustained or intermittent muscular contraction of both eyelids and upper facial muscles which cause closure of eyelids, abnormal facial expressions and distress [1]. The term dystonia is an...

Supplements

Welcome to our supplements, please select a name and the issue will appear.

What’s new in wet AMD papers?

Paper presentations on neovascular (‘wet’) age-related macular degeneration (AMD) from the 16th European Society of Retina Specialists Congress, Copenhagen, September 2016, outline recent research directions evaluating the impact of vision loss on key health domains, patient preferences in the process...

Introduction of the Mydriasert insert at the Manchester Royal Eye Hospital

The authors report on a study to examine the effects of the Mydriasert insert on time, effects, patient comfort and tolerability at Manchester Royal Eye Hospital. Mydriasert is an insoluble ophthalmic insert indicated for mydriasis prior to ophthalmic surgery, which...